3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC

Inhalation anesthesia relies on establishing and maintaining a series of partial pressure gradients from the anesthesia delivery system to the patient's brain: $P_{circuit} \rightarrow P_{alveoli}\ (P_A) \rightarrow P_{arterial}\ (P_a) \rightarrow P_{brain}\ (P_{br})$. Because volatile anesthetics equilibrate according to partial pressure rather than total concentration, the ultimate determinant of anesthetic depth in the central nervous system is the alveolar partial pressure ($P_A$).

---

1. Physicochemical Properties & Partition Coefficients

Partition coefficients describe the relative distribution of an anesthetic agent between two phases at equilibrium (equal partial pressure) at 37°C. They reflect solubility and determine both speed of onset and potency.

Core Physical Constants of Inhalation Agents

Clinical Implications of Solubility

• Blood/Gas Partition Coefficient ($\lambda_{b/g}$): Measures blood solubility. Agents with low blood solubility (Desflurane = 0.42, $N_2O$ = 0.47, Sevoflurane = 0.65) saturate the small blood compartment rapidly, allowing alveolar partial pressure ($P_A$) to equilibrate with inspired partial pressure ($P_I$) quickly, yielding rapid induction and rapid emergence. Agents with high blood solubility (Isoflurane = 1.40, Halothane = 2.54) dissolve extensively in pulmonary capillary blood, slowing the rise of $P_A$ and delaying induction and emergence.
• Oil/Gas Partition Coefficient ($\lambda_{o/g}$): Measures lipid solubility and directly reflects anesthetic potency according to the Meyer-Overton rule (Potency $\propto \lambda_{o/g} \propto 1/\text{MAC}$). Isoflurane ($\lambda_{o/g} = 99$) is far more potent than Desflurane ($\lambda_{o/g} = 18.7$).
• Molecular Target Sites: Volatile agents bind to specific hydrophobic cavities on ligand-gated ion channels in the CNS, positively modulating inhibitory $GABA_A$ and glycine receptors while inhibiting excitatory nicotinic acetylcholine, $5-HT_3$, AMPA, and NMDA receptors, as well as opening two-pore domain potassium channels (TREK, TASK).

---

2. Determinants of Alveolar Partial Pressure Rise ($F_A/F_I$ Ratio)

The rate at which the alveolar fraction ($F_A$) approaches the inspired fraction ($F_I$) dictates the speed of induction. The $F_A/F_I$ curve represents this dynamic equilibration.

$\text{Rate of } F_A \text{ Rise} = \text{Delivery to Alveoli} - \text{Uptake by Pulmonary Blood}$

Alveolar Delivery Factors (Increase $F_A/F_I$)

1. Inspired Gas Concentration ($F_I$): High dial settings accelerate the increase in alveolar concentration ($P_A$).
2. Alveolar Ventilation ($\dot{V}_A$): Hyperventilation constantly replenishes anesthetic removed by blood uptake, steepening the $F_A/F_I$ curve. This effect is most pronounced for soluble agents (Isoflurane) because rapid uptake continuously depletes their alveolar pool.
3. Breathing Circuit Volume & Fresh Gas Flow (FGF): High FGF (e.g., 6–10 L/min) and low internal circuit volume wash out circuit dead space rapidly, matching delivered machine concentration to inspired mask concentration.

Alveolar Uptake Factors (Decrease $F_A/F_I$)

$\text{Uptake} = \lambda_{b/g} \times Q \times (P_A - P_v)$

Where $\lambda_{b/g}$ is the blood/gas partition coefficient, $Q$ is cardiac output, and $(P_A - P_v)$ is the alveolar-to-mixed venous partial pressure gradient.

1. Solubility ($\lambda_{b/g}$): Highly soluble agents have massive uptake, depressing the $F_A/F_I$ curve.
2. Cardiac Output ($Q$):
   • High Cardiac Output: Increases pulmonary blood flow, carrying more anesthetic away from alveoli into tissues per unit time. This paradoxically slows the rise of $F_A/F_I$, delaying induction (greatest effect on soluble agents).
   • Low Cardiac Output (Shock / Heart Failure): Decreases uptake, leading to a rapid rise in $F_A/F_I$, which predisposes patients to precipitous anesthetic overdose and profound myocardial depression.
3. Alveolar-to-Venous Difference ($P_A - P_v$): Reflects tissue uptake. Early in induction, venous blood returning to the lungs contains zero anesthetic ($P_v = 0$), maximizing $(P_A - P_v)$ and uptake. As vessel-rich group (VRG) tissues saturate, $P_v$ rises toward $P_A$, decreasing net uptake and allowing $F_A$ to approach $F_I$.

Tissue Groups and Saturation Dynamics

Impact of Intracardiac Shunts

• Right-to-Left Shunt (e.g., Tetralogy of Fallot): Venous blood bypasses the lungs and dilutes blood containing anesthetic from ventilated alveoli. This slows the rate of induction with inhalation agents. The effect is most pronounced for insoluble agents (Desflurane, $N_2O$) because their uptake is normally so rapid that dilution significantly dampens arterial partial pressure rise.
• Left-to-Right Shunt (e.g., VSD, PDA): Recirculates anesthetic-rich blood back through pulmonary circulation. Causes minimal clinically observable change on induction speed.

---

3. Gas Physics Phenomena

The Concentration Effect

Delivering a higher inspired concentration ($F_I$) increases the rate of rise of $F_A/F_I$ through two mechanisms:

1. Concentrating Effect: Rapid uptake of a large volume of gas leaves the remaining gas in a smaller residual alveolar volume, concentrating the remaining molecules.
2. Augmentation of Inflow (Ventilatory Effect): The loss of alveolar gas volume creates a relative subatmospheric pressure that draws an increased volume of fresh gas into the alveoli during spontaneous ventilation.

The Second Gas Effect

The rapid uptake of large volumes of a primary gas (typically 50–70% $N_2O$) concentrates a companion volatile agent (the "second gas," e.g., 2% Sevoflurane) and accelerates the rise of the companion agent's alveolar partial pressure and arterial tension.

Diffusion Hypoxia (The Fink Effect)

Upon cessation of $N_2O$ delivery at the conclusion of anesthesia, highly insoluble $N_2O$ rapidly diffuses from blood into alveoli along its steep concentration gradient. This massive outpouring of $N_2O$ into the alveoli dilutes alveolar oxygen and carbon dioxide, producing transient arterial hypoxemia and hypocarbia (which blunts respiratory drive). Prevention: Administer 100% $O_2$ for 5–10 minutes after turning off $N_2O$.

Closed Air Space Expansion

Nitrous oxide is 31 to 34 times more soluble in blood than nitrogen ($\lambda_{b/g}$ of $N_2O = 0.47$ vs $N_2 = 0.015$). Consequently, $N_2O$ diffuses into closed, gas-containing spaces far more rapidly than nitrogen can diffuse out.

• Compliant cavities (bowel loops, pneumothorax, subcutaneous emphysema, endotracheal tube cuffs) expand dramatically in volume (a 75% $N_2O$ mixture can double a pneumothorax in 10 minutes and triple it in 30 minutes).
• Non-compliant cavities (middle ear, cerebral ventricles after pneumoencephalography, ocular gas bubbles like $SF_6$ or $C_3F_8$) experience dangerous increases in internal pressure.
• Contraindications to $N_2O$: Tension pneumothorax, bowel obstruction/ileus, venous air embolism, tympanic membrane grafting, recent retinal vitrectomy with intraocular gas bubble (avoid for 4 weeks with $SF_6$, 8 weeks with $C_3F_8$), severe pulmonary hypertension (increases PVR).

---

4. Minimum Alveolar Concentration (MAC)

Definition: Minimum Alveolar Concentration (MAC) is the steady-state alveolar concentration of an inhaled anesthetic at 1 atmosphere of pressure that prevents skeletal muscle movement in response to a standard supramaximal noxious stimulus (surgical skin incision) in 50% of patients ($ED_{50}$).

Key MAC Subtypes

• 1.0 MAC ($ED_{50}$): 50% of patients do not move.
• 1.3 MAC ($ED_{95}$): Concentration preventing movement in 95% of the population ($1.3 \times \text{standard MAC}$). Standard clinical target for surgical maintenance.
• MAC-Awake (0.3–0.5 MAC): Alveolar concentration at which 50% of patients open their eyes to verbal command upon emergence. Suppresses voluntary response and explicit memory.
• MAC-BAR (1.5–2.0 MAC): Alveolar concentration that Blocks the Adrenergic Response to surgical incision (prevents intraoperative tachycardia and hypertension without adjuvant opioids).
• MAC-Intubation (MAC-EI, ~1.3 MAC): Prevents movement or coughing during endotracheal intubation in 50% of non-paralyzed patients.

Baseline MAC Values (at 1 atm, 40 years old, 100% $O_2$)

MAC Additivity Principle: Fractional MAC values are strictly additive. For example, delivering 0.5 MAC Sevoflurane (1.0%) + 0.5 MAC $N_2O$ (52%) achieves 1.0 MAC total depth of general anesthesia.

5. Physiologic and Pharmacologic Modifiers of MAC

Understanding factors that alter MAC is critical for avoiding intraoperative awareness or severe overdose.

Factors That Alter MAC

---

6. Biotransformation, Degradation & Toxicities

Hepatic Metabolism (Rule of 2s)

Volatile anesthetics undergo hepatic cytochrome P450 (predominantly CYP2E1) oxidative metabolism. The relative extent of biotransformation follows the descending order:

$\text{Methoxyflurane (50\%)} > \text{Halothane (20\%)} > \text{Sevoflurane (2-5\%)} > \text{Isoflurane (0.2\%)} > \text{Desflurane (0.02\%)} > \text{N}_2\text{O (0.004\% by gut flora)}$

• Halothane Hepatitis: Oxidative metabolism generates reactive trifluoroacetyl chloride haptens that bind to hepatic microsomal proteins. In susceptible individuals (often obese females with multiple exposures), this triggers an autoimmune response causing fulminant centrilobular hepatic necrosis (1 in 10,000 to 35,000). Cross-sensitization with Isoflurane and Desflurane is possible but extremely rare.
• Inorganic Fluoride Toxicity: Sevoflurane produces hexafluoroisopropanol (HFIP) and inorganic fluoride ($F^-$) via CYP2E1 breakdown. Although plasma fluoride levels may exceed $50\ \mu\text{mol/L}$ during prolonged Sevoflurane anesthesia, HFIP is rapidly glucuronidated and excreted, preventing the high-output nephrogenic diabetes insipidus classically seen with methoxyflurane.

Degradation by Carbon Dioxide Absorbents

When volatile agents pass through alkaline $CO_2$ absorbents (soda lime, barium hydroxide lime / Baralyme), chemical breakdown reactions occur:

1. Compound A (Fluoromethyl-2,2-difluoro-1-[trifluoromethyl]vinyl ether):
   • Mechanism: Degradation of Sevoflurane by strong bases (potassium hydroxide $KOH$ or sodium hydroxide $NaOH$) in $CO_2$ absorbents.
   • Risk Factors: Low fresh gas flow (<1 L/min), barium hydroxide lime > soda lime, high absorbent temperatures, high Sevoflurane concentrations, desiccated absorbent.
   • Toxicity: Produces proximal tubular necrosis in animal models.
   • FDA Recommendations: Use fresh gas flow $\ge 1\text{ L/min}$ for procedures lasting up to 2 hours, and $\ge 2\text{ L/min}$ for cases exceeding 2 hours. Closed-circuit anesthesia with Sevoflurane at $<1\text{ L/min}$ is contraindicated.
2. Carbon Monoxide ($CO$) Generation:
   • Mechanism: Direct breakdown of volatile agents containing a difluoromethoxy group ($-\text{CHF}_2$) when exposed to completely dry/desiccated strong-base absorbents.
   • Agent Propensity: $\text{Desflurane} > \text{Enflurane} > \text{Isoflurane} \gg \text{Sevoflurane}$.
   • Clinical Presentation: Elevated carboxyhemoglobin ($COHb$) levels, tissue hypoxia, falsely elevated pulse oximeter readings ($SpO_2$), and cherry-red venous blood. Typically occurs on Monday mornings after high fresh gas flows were left running over the weekend, desiccating the absorbent canisters.